The cannabis industry is still showing signs of profitability, with companies reporting strong 2025 earnings. Much of the legal market, even with its uphill battle, is standing strong. This shows people that even though it is not federally legal, there is still an abundance of success at the state level. As well as other legal markets in various global regions, all of which play a big role as a whole for cannabis.
Investing in marijuana stocks amid market volatility needs a strategic approach, balancing potential growth with inherent risks. Currently, the U.S. cannabis industry is experiencing a period of both challenge and opportunity. While the sector continues to grow with legal cannabis sales breaking the billion mark, investors face headwinds such as regulatory uncertainties, and price reduction.
Curaleaf Holdings, Inc. (OTCPK:CURLF) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Corporate Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Chairman and Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Matt Bottomley - Canaccord Russell Stanley - Beacon Securities Operator Good day, and welcome to the Curaleaf Holdings, Inc., First Quarter 2025 Conference Call. All participants will be in listen-only mode.
Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.07 per share a year ago.
There's a lot of concern in the markets these days with how tariffs will affect growth stocks like Nvidia and Apple and whether they drag down their earnings.
The U.S. cannabis market continues to expand rapidly, with expected revenues reaching over $45 billion by 2025. This growth is fueled by rising consumer demand and ongoing state-level legalization. So far, 24 states and Washington, D.C. have legalized adult-use marijuana. Nearly 80% of Americans now live near a dispensary. Although federal reform has faced challenges, momentum continues to build. Most recently, a major legalization proposal in Florida failed to meet the required 60% threshold. However, efforts remain active across other key states. Many investors are now focused on the DEA's expected rescheduling of cannabis. This move could reduce tax burdens and increase medical research. With this news circulating, top marijuana stocks are showing renewed volatility and opportunity this week.
With the tariffs in place, will marijuana stocks continue to stay on the floor? Or is this the time to get active in response to the market as a whole being down? At this time, there are several paths to choose from, all having an unpredictable outcome. The reason for the unknowns is that no one knows what these new tariffs will bring exactly. So people are using the knowledge and principles they know to make better investments.
Those invested in cannabis stocks understand that taking profits has been a struggle. There is a hefty level of volatile trading that has kept the sector on a downward trend. This trend is what makes any sector, including cannabis nearly impossible to be profitable. At one time marijuana stocks showed healthy trading even in a down trend. Over the last few years, the trading behavior of public cannabis companies has changed drastically.
Curaleaf Holdings recently reported in-line financial results for Q4-2024 and FY2024. The company saw expansion in its revenue from international sales but contraction domestically. Revenue growth for FY2024 was flat compared to FY2023.
Marijuana stock investors are on edge with all this uncertainty surrounding the industry. With Donald Trump as our new president, there has been fear of what may become of the legal cannabis industry. Many feel that this will impact not only how marijuana stocks perform but also the small craft legal operators. At this time, there is a split between corporate cannabis-like MSOs such as Truleive versus small-batch farmers. For the small-batch legal operators, it has been tough to deal with the increase in taxes and regulatory concerns that make operating the business more challenging.
Curaleaf Holdings, Inc. (OTCPK:CURLF) Q4 2024 Earnings Conference Call March 1, 2025 5:00 PM ET Company Participants Camilo Lyon - Chief Investment Officer Boris Jordan - Chairman and Chief Executive Officer Ed Kremer - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Russell Stanley - Beacon Securities Matt Bottomley - Canaccord Genuity Bill Kirk - ROTH Capital Partners Eric Des Lauriers - Craig-Hallam Capital Group Pablo Zuanic - Zuanic & Associates Operator Good day and welcome to the Curaleaf Holdings Fourth Quarter and Fiscal Year End 2024 Earnings Conference Call. All participants will be in a listen-only mode.
Curaleaf Holdings, Inc. (CURLF) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.01 per share a year ago.